JP2023082054A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023082054A5 JP2023082054A5 JP2023047827A JP2023047827A JP2023082054A5 JP 2023082054 A5 JP2023082054 A5 JP 2023082054A5 JP 2023047827 A JP2023047827 A JP 2023047827A JP 2023047827 A JP2023047827 A JP 2023047827A JP 2023082054 A5 JP2023082054 A5 JP 2023082054A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- amino acid
- acid sequence
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Claims (1)
- 前記改変タンパク質は、ＳＥＱ ＩＤ ＮＯＳ：１－２およびＳＥＱ ＩＤ ＮＯＳ：１２－１５からなる群から選択されるアミノ酸配列を有する、請求項１～１０のいずれかに記載の方法。
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762460118P | 2017-02-17 | 2017-02-17 | |
| US62/460,118 | 2017-02-17 | ||
| JP2019544016A JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
| PCT/US2018/018557 WO2018152451A1 (en) | 2017-02-17 | 2018-02-17 | Targeted ligand-payload based drug delivery for cell therapy |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544016A Division JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023082054A JP2023082054A (ja) | 2023-06-13 |
| JP2023082054A5 true JP2023082054A5 (ja) | 2023-07-19 |
Family
ID=63170493
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544016A Active JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
| JP2023047827A Pending JP2023082054A (ja) | 2017-02-17 | 2023-03-24 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019544016A Active JP7288402B2 (ja) | 2017-02-17 | 2018-02-17 | 細胞医療用の標的リガンド－ペイロードによる薬剤デリバリー |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200054676A1 (ja) |
| EP (1) | EP3583218A4 (ja) |
| JP (2) | JP7288402B2 (ja) |
| KR (1) | KR102595249B1 (ja) |
| CN (1) | CN110662839A (ja) |
| AU (1) | AU2018221171B2 (ja) |
| CA (1) | CA3053534A1 (ja) |
| WO (1) | WO2018152451A1 (ja) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11225520B2 (en) | 2016-02-16 | 2022-01-18 | Dana-Farber Cancer Institute, Inc. | Immunotherapy compositions and methods |
| EP3579870A4 (en) | 2017-02-07 | 2020-12-30 | Seattle Children's Hospital (DBA Seattle Children's Research Institute) | PHOSPHOLIPID ETHER (PLE) T CAR-LYMPHOCYTE TUMOR (CTCT) TARGETING AGENTS |
| JP7178355B2 (ja) | 2017-02-28 | 2022-11-25 | エンドサイト・インコーポレイテッド | Ｃａｒ ｔ細胞療法のための組成物および方法 |
| CA3089051A1 (en) | 2018-01-22 | 2019-07-25 | Endocyte, Inc. | Methods of use for car t cells |
| CA3108710A1 (en) * | 2018-08-07 | 2020-02-13 | Purdue Research Foundation | Rejuvenation of car t cell |
| TW202115126A (zh) | 2019-06-11 | 2021-04-16 | 美商舒爾人類基因療法公司 | 用於治療血漿激肽釋放酶失調所介導之疾病的抗體腺相關病毒載體遞送 |
| EP4048800A1 (en) | 2019-10-23 | 2022-08-31 | Shire Human Genetic Therapies, Inc. | Adeno-associated virus vectors based gene therapy for hereditary angioedema |
| WO2022044024A1 (en) * | 2020-08-31 | 2022-03-03 | Ramot At Tel-Aviv University Ltd. | Small molecule modulators of gsk-3 activity |
| EP4263614A1 (en) | 2020-12-16 | 2023-10-25 | Takeda Pharmaceutical Company Limited | Adeno associated viral vector delivery of antibodies for the treatment of disease mediated by dysregulated plasma kallikrein |
| US20240043529A1 (en) * | 2020-12-22 | 2024-02-08 | Eutropics Pharmaceuticals, Inc. | Methods and compositions related to bcl2 and bim heterodimer antibodies |
| CN113462649B (zh) * | 2021-05-27 | 2022-08-23 | 浙江大学 | Mek抑制剂在减少car-t细胞耗竭和终末分化中的应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9523469D0 (en) * | 1995-11-16 | 1996-01-17 | Sandoz Ltd | Organic compounds |
| US6093382A (en) * | 1998-05-16 | 2000-07-25 | Bracco Research Usa Inc. | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications |
| CA2440610C (en) * | 2001-03-09 | 2011-07-12 | Board Of Regents, The University Of Texas System | Induction of tumor immunity by variants of folate binding protein |
| US20080260812A1 (en) * | 2004-04-26 | 2008-10-23 | Takami Matsuyama C/O Kagoshima University | Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta) |
| KR20120018762A (ko) * | 2009-04-08 | 2012-03-05 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 제어된 혈청 약동학적 특성을 갖는 인간 단백질 스캐폴드 |
| US20120258905A1 (en) * | 2009-12-23 | 2012-10-11 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| US20190054117A1 (en) * | 2014-12-19 | 2019-02-21 | Novartis Ag | Dimerization switches and uses thereof |
| WO2016164745A1 (en) * | 2015-04-10 | 2016-10-13 | The Methodist Hospital System | Cd117 ligand-drug conjugates for targeted cancer therapy |
| WO2017027843A1 (en) * | 2015-08-12 | 2017-02-16 | Massachusetts Institute Of Technology | Cell surface coupling of nanoparticles |
| KR20180101540A (ko) * | 2016-01-15 | 2018-09-12 | 이투빅스 코포레이션 | T 세포 면역요법을 위한 방법 및 조성물 |
| EP3529268A1 (en) * | 2016-10-19 | 2019-08-28 | The Scripps Research Institute | Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof |
| KR20190072639A (ko) * | 2016-11-02 | 2019-06-25 | 유니버시타트 바셀 | 세포 치료에 사용하기 위한 면역학적으로 식별 가능한 세포 표면 변이체 |
-
2018
- 2018-02-17 WO PCT/US2018/018557 patent/WO2018152451A1/en unknown
- 2018-02-17 CN CN201880024308.6A patent/CN110662839A/zh active Pending
- 2018-02-17 CA CA3053534A patent/CA3053534A1/en active Pending
- 2018-02-17 US US16/486,632 patent/US20200054676A1/en active Pending
- 2018-02-17 AU AU2018221171A patent/AU2018221171B2/en active Active
- 2018-02-17 EP EP18754879.7A patent/EP3583218A4/en active Pending
- 2018-02-17 JP JP2019544016A patent/JP7288402B2/ja active Active
- 2018-02-17 KR KR1020197026818A patent/KR102595249B1/ko active IP Right Grant
-
2023
- 2023-03-24 JP JP2023047827A patent/JP2023082054A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023082054A5 (ja) | ||
| JP2018138049A5 (ja) | ||
| JP2019122392A5 (ja) | ||
| JP2017018125A5 (ja) | ||
| JP2018171063A5 (ja) | ||
| JP2010510315A5 (ja) | ||
| DE602005020165D1 (de) | Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin | |
| JP2005120106A5 (ja) | ||
| CY1112833T1 (el) | Καινοφανης προσδετης της κυτοκινης ζcυτοr17 | |
| JP2019214579A5 (ja) | ||
| JP2003515323A5 (ja) | ||
| JP2009268467A5 (ja) | ||
| JP2019500414A5 (ja) | ||
| JP2007508034A5 (ja) | ||
| WO2007029262A3 (en) | Compositions and methods using same for the detection of viruses | |
| JP2008517998A5 (ja) | ||
| MX2021004714A (es) | Proteina cas9 modificada, y uso de la misma. | |
| WO2004035618A3 (en) | Nucleic acids coding for adhesion factor of group b streptococcus, adhesion factors of group b streptococcus and further uses thereof | |
| JP2018529626A5 (ja) | ||
| JP2018191647A5 (ja) | ||
| JPWO2020027010A5 (ja) | ||
| MX2021001507A (es) | Farmaco de diagnostico y metodo de diagnostico para la enfermedad de alzheimer. | |
| RU2017104284A (ru) | Выделенные полипептиды cd44 и их применение | |
| JP2019512693A5 (ja) | ||
| JP2020127419A5 (ja) |